Axin: A master scaffold for multiple signaling pathways

NeuroSignals

Volumn 13, Issue 3, 2004, Pages 99-113

  Luo, Wen ^b   Lin, Sheng Cai ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b NONE

Author keywords

Axin, biological function; Axin, identification; Axin JNK signaling pathway; Wnt pathway

Indexed keywords

AXIN; BETA CATENIN; CASEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; STRESS ACTIVATED PROTEIN KINASE; WNT PROTEIN;

APOPTOSIS; BIODIVERSITY; CARCINOGENESIS; CELL FUNCTION; DIMERIZATION; DOWN REGULATION; ENZYME ACTIVATION; GENE DISRUPTION; GENE LOCUS; GENE REPRESSION; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BETA CATENIN; CYTOSKELETAL PROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 1842507650     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076563     Document Type: Review

References (133)

1. Wodarz A, Nusse R: Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998;14:59-88.
2. Pandur P, Maurus D, Kuhl M: Increasingly complex: New players enter the Wnt signaling network. Bioessays 2002;24:881-884.
3. Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D: Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 2001;7:801-809.
4. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel D: arrow encodes an LDL-receptor-related protein essential for Wingless signaling. Nature 2000;407:527-530.
5. Tolwinski NS, Wehrli M, Rives A, Erdeniz N, DiNardo S, Wieschaus E: Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/GSK-3β activity. Dev Cell 2003;4:407-418.
6. Kishida S, Yamamoto H, Hino S, Ikeda M, Kishida M, Kikuchi A: DIX domains of Dvl and Axin are necessary for protein interactions and their ability to regulate β-catenin stability. Mol Cell Biol 1999;19:4414-4422.
7. Li L, Yuan H, Weaver CD, Mao J, Farr GH, Sussman DJ, Jonkers J, Kimelman D, Wu D: Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J 1999;18:4233-4240.
8. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, Kikuchi A: Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J Biol Chem 1998;273:10823-10826.
9. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P: Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK-3β. Curr Biol 1998;8:573-581.
10. Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, Akiyama T: Axin, an inhibitor of the Wnt signaling pathway, interacts with β-catenin, GSK-3β and APC and reduces the β-catenin level. Genes Cells 1998;3:395-403.
11. Rubinfeld B, Tice DA, Polakis P: Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase Iε. J Biol Chem 2001;276:39037-39045.
12. Hsu W, Zeng L, Costantini F: Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem 1999;274:3439-3445.
13. Schwarz-Romond T, Asbrand C, Bakkers J, Kuhl M, Schaeffer HJ, Huelsken J, Behrens J, Hammerschmidt M, Birchmeier W: The ankyrin repeat protein diversin recruits casein kinase Iε to the β-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling. Genes Dev 2002;16:2073-2084.
14. Shiomi K, Uchida H, Keino-Masu K, Masu M: Ccd1, a novel protein with a DIX domain, is a positive regulator in the Wnt signaling during zebrafish neural patterning. Curr Biol 2003;13:73-77.
15. Kadoya T, Kishida S, Fukui A, Hinoi T, Michiue T, Asashima M, Kikuchi A: Inhibition of Wnt signaling pathway by a novel Axin-binding protein. J Biol Chem 2000;275:37030-37037.
16. Cliffe A, Hamada F, Bienz M: A role of Dishevelled in relocating axin to the plasma membrane during wingless signaling. Curr Biol 2003;13:960-966.
17. Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A: Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3β regulates its stability. J Biol Chem 1999;274:10681-10684.
18. Zhang Y, Neo SY, Wang X, Han J, Lin SC: Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem 1999;274:35247-35254.
19. Luo W, Ng WW, Jin LH, Ye Z, Han J, Lin SC: Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation. J Biol Chem 2003;278:37451-37458.
20. Kusano S, Raab-Traub N: I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Mol Cell Biol 2002;22:6393-6405.
21. Yamazaki H, Nusse R: Identification of DCAP, a Drosophila homolog of a glucose transport regulatory complex. Mech Dev 2002;119:115-119.
22. Cowan CA, Henkemeyer M: The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature 2001;413:174-179.
23. Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M: Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. Mol Cell Biol 2001;21:5132-5141.
24. Zhang Y, Qiu WJ, Liu DX, Neo SY, He X, Lin SC: Differential molecular assemblies underlie the dual function of Axin in modulating the Wnt and JNK pathways. J Biol Chem 2001;276:32152-32159.
25. Zhang Y, Neo SY, Han J, Lin SC: Dimerization choices control the ability of Axin and dishevelled to activate c-Jun N-terminal kinase/stress-activated protein kinase. J Biol Chem 2000;275:25008-25014.
26. Zhang Y, Qiu WJ, Chan SC, Han J, He X, Lin SC: Casein kinase I and casein kinase II differentially regulate Axin function in Wnt and JNK pathways. J Biol Chem 2002;277:17706-17712.
27. Rui HL, Fan E, Zhou HM, Xu Z, Zhang Y, Lin SC: SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J Biol Chem 2002;277:42981-42986.
28. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F: The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997;90:181-192.
29. Lyon MF, Rastan S, Brown SD: Genetic Variants and Strains of the Laboratory Mouse. Oxford, Oxford University Press, 1996.
30. Ruvinsky A, Flood WD, Zhang T, Costantini F: Unusual inheritance of the Axin Fu mutation in mice is associated with widespread rearrangements in the proximal region of chromosome 17. Genet Res 2000;76:135-147.
31. Vasicek TJ, Zeng L, Guan XJ, Zhang T, Costantini F, Tilghman SM: Two dominant mutations in the mouse fused gene are the result of transposon insertions. Genetics 1997;147:777-786.
32. Fu allele occurs after maternal and paternal transmission. Proc Natl Acad Sci USA 2003;100:2538-2543.
33. Gluecksohn-Schoenheimer S: The effects of a lethal mutation responsible for duplications and twinning in mouse embryos. J Exp Zool 1949;110:47-76.
34. Jacobs-Cohen RJ, Spiegelman M, Cookingham JC, Bennett D: Knobbly, a new dominant mutation in the mouse that affects embryonic ectoderm organization. Genet Res 1984;43:43-50.
35. Perry WL, Vasicek TJ, Lee JJ, Rossi JM, Zeng L, Zhang T, Tilghman SM, Costantini F: Phenotypic and molecular analysis of a transgenic insertional allele of the mouse Fused locus. Genetics 1995;141:321-332.
36. Druey KM, Blumer KJ, Kang VH, Kehrl JH: Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 1996;379:742-746.
37. Burchett SA: Regulators of G protein signaling: A bestiary of modular protein binding domains. J Neurochem 2000;75:1335-1351.
38. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A: Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 1998;17:1371-1384.
39. Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M, Kikuchi A: Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol 1998;18:2867-2875.
40. Behrens J, Jerchow BA, Wurele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W: Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 1998;280:596-599.
41. Hedgepeth CM, Deardorff MA, Klein PS: Xenopus axin interacts with glycogen synthase kinase-3β and is expressed in the anterior midbrain. Mech Dev 1999;80:147-151.
42. Hamada F, Tomoyasu Y, Takatsu Y, Nakamura M, Nagai S, Suzuki A, Fujita F, Shibuya H, Toyoshima K, Ueno N, Akiyama T: Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin. Science 1999;283:1739-1742.
43. Korswagen HC, Coudreuse DY, Betist MC, van de Water S, Zivkovic D, Clevers HC: The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans. Genes Dev 2002;16:1291-1302.
44. Peifer M, Polakis P: Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 2000;287:1606-1609.
45. Sakanaka C, Weiss JB, Williams LT: Bridging of β-catenin and glycogen synthase kinase-3β by axin and inhibition of β-catenin- mediated transcription. Proc Natl Acad Sci USA 1998;95:3020-3023.
46. Fagotto F, Jho E, Zeng L, Kurth T, Joos T, Kaufmann C, Costantini F: Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol 1999;145:741-756.
47. Willert K, Logan CY, Arora A, Fish M, Nusse R: A Drosophila Axin homolog, Daxin, inhibits Wnt signaling. Development 1999;126:4165-4173.
48. Farr GH 3rd, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D: Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol 2000;148:691-702.
49. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T: AXIN1 mutations in hepatocellular carcinomas and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000;24:245-250.
50. Miao J, Kusafuka T, Udatsu Y, Okada A: Sequence variants of the Axin gene in hepatoblastoma. Hepatol Res 2003;25:174-179.
51. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W: Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 2002;31:4863-4871.
52. Neo SY, Zhang Y, Yaw LP, Li P, Lin SC: Axin-induced apoptosis depends on the extent of its JNK activation and its ability to down-regulate β-catenin levels. Biochem Biophys Res Commun 2000;272:144-150.
53. Hsu W, Shakya R, Costantini F: Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. J Cell Biol 2001;155:1055-1064.
54. Webster MT, Rozycka M, Sara E, Davis E, Smalley M, Young N, Dale TC, Wooster R: Sequence variants of the axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer 2000;28:443-453.
55. Yokota N, Nishizawa S, Ohta S, Date H, Sugimura H, Namba H, Maekawa M: Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 2002;101:198-201.
56. Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsch T: Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001;61:7039-7043.
57. Baeza N, Masuoka J, Kleihues P, Ohgaki H: AXIN1 mutants but not deletions in cerebellar medulloblastomas. Oncogene 2003;22:632-636.
58. Jin LH, Shao QJ, Luo W, Ye ZY, Li Q, Lin SC: Detection of point mutations of the Axin1 gene in colorectal cancers. Int J Cancer 2003;107:696-699.
59. Habas R, Kato Y, He X: Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein, Daam1. Cell 2001;107:843-854.
60. Tada M, Smith JC: Xwnt11 is a target of Xenopus Brachyury: Regulation of gastrulation movements via Dishevelled, but not through the canonical Wnt pathway. Development 2000;127:2227-2238.
61. Wallingford JB, Rowning BA, Vögeli KM, Rothbacher U, Fraser SE, Harland RM: Dishevelled controls cell polarity during Xenopus gastrulation. Nature 2000;405:81-85.
62. Gho M, Schweisguth F: Frizzled signalling controls orientation of asymmetric sense organ precursor cell divisions in Drosophila. Nature 1998;393:178-181.
63. Cadigan KM, Nusse R: Wnt signaling: A common theme in animal development. Genes Dev 1997;11:3286-3305.
64. Capelluto DG, Kutateladze TG, Habas R, Finkielstein CV, He X, Overduin M: The DIX domain targets dishevelled to actin stress fibres and vesicular membranes. Nature 2002;419:726-729.
65. Christian JL, Moon RT: Interactions between Xwnt-8 and Spemann organizer signaling pathways generate dorsoventral pattern in the embryonic mesoderm of Xenopus. Genes Dev 1993;7:13-28.
66. Greenspan RJ, O'Brien MC: Genetic analysis of mutations at the fused locus in the mouse. Proc Natl Acad Sci USA 1986;83:4413-4417.
67. Spink KE, Polakis P, Weis WI: Structural basis of the axin-adenomatous polyposis coli interaction. EMBO J 2000;19:2270-2279.
68. Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M: Nuclear export of the APC tumor suppressor controls beta-catenin function in transcription. EMBO J 2003;22:1101-1113.
69. Henderson BR, Fagotto F: The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep 2002;3:834-839.
70. Ahmed Y, Hayashi S, Levine A, Wieschaus E: Regulation of armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development. Cell 1998;93:1171-1182.
71. Hinoi T, Yamamoto H, Kishida M, Takada S, Kishida S, Kikuchi A: Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3β-dependent phosphorylation of beta-catenin and down-regulates beta-catenin. J Biol Chem 2000;275:34399-34406.
72. Kawahara K, Morishita T, Nakamura T, Hamada F, Toyoshima K, Akiyama T: Down-regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and β-catenin. J Biol Chem 2000;275:8369-8374.
73. Rubinfeld B, Albert I, Porfiri E, Munemitsu S, Polakis P: Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 1997;57:4624-4630.
74. Itoh K, Krupnik VE, Sokol SY: Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin. Curr Biol 1998;8:591-594.
75. Ding Y, Dale T: Wnt signal transduction: Kinase cogs in a nano-machine? Trends Biochem Sci 2002;27:327-329.
76. Dajani R, Fraser E, Roe SM, Yeo M, Good VM, Thompson V, Dale TC, Pearl LH: Structural basis for recruitment of glycogen synthase kinase 3β to the axin-APC scaffold complex. EMBO J 2003;22:494-501.
77. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR: Glycogen synthase kinase-3: Functions in oncogenesis and development. Biochim Biophys Acta 1992;1114:147-162.
78. Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E: Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett 1992;314:315-321.
79. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P: Binding of GSK-3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996;272:1023-1026.
80. Fujimuro M, Wu FY, ApRhys C, Kajumbula H, Young DB, Hayward GS, Hayward SD: A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 2003;9:300-306.
81. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002;108:837-847.
82. Gumbiner BM, McCrea PD: Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci Suppl 1993;17:155-158.
83. Schneider S, Herrenknecht K, Butz S, Kemler R, Hausen P: Catenins in Xenopus embryogenesis and their relation to the cadherin-mediated cell-cell adhesion system. Development 1993;118:629-640.
84. Gottardi CJ, Gumbiner BM: Adhesion signaling: How β-catenin interacts with its partners. Curr Biol 2001;11:R792-R794.
85. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W: Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996;382:638-642.
86. Gumbiner BM: Signal transduction of beta-catenin. Curr Opin Cell Biol 1995;7:634-640.
87. Peifer M, Orsulic S, Pai LM, Loureiro J: A model system for cell adhesion and signal transduction in Drosophila. Dev Suppl 1993:163-176.
88. Papkoff J, Rubinfeld B, Schryver B, Polakis P: Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol Cell Biol 1996;16:2128-2134.
89. Peifer M, Sweeton D, Casey M, Wieschaus E: Wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo. Development 1994;120:369-380.
90. Aberle HA, Bauer A, Stappert J, Kispert A, Kemler R: β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997;16:3797-3804.
91. Brannon M, Gomperts M, Sumoy L, Moon RT, Kimelman D: A β-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev 1997;11:2359-2370.
92. Laurent MN, Blitz IL, Hashimoto C, Rothbacher U, Cho KW: The Xenopus homeobox gene twin mediates Wnt induction of goosecoid in establishment of Spemann's organizer. Development 1997;124:4905-4916.
93. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H: XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996;86:391-399.
94. McKendry R, Hsu SC, Harland RM, Grosschedl R: LEF-1/TCF proteins mediate wnt-inducible transcription from the Xenopus nodal-related 3 promoter. Dev Biol 1997;192:420-431.
95. Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
96. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
97. Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM: Regulation of β-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 1999;283:2089-2091.
98. Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A: GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with Axin. Oncogene 2000;19:537-545.
99. Ratcliffe MJ, Itoh K, Sokol SY: A positive role for the PP2A catalytic subunit in Wnt signal transduction. J Biol Chem 2000;275:35680-35683.
100. Yamamoto H, Hinoi T, Michiue T, Fukui A, Usui H, Janssens V, Van Hoof C, Goris J, Asashima M, Kikuchi A: Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A. J Biol Chem 2001;276:26875-26882.
101. Li X, Yost HJ, Virshup DM, Seeling JM: Protein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus. EMBO J 2001;20:4122-4131.
102. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P: Association of the APC gene product with beta-catenin. Science 1993;262:1731-1734.
103. Fish KJ, Cegielska A, Getman ME, Landes GM, Virshup DM: Isolation and characterization of human casein kinase I epsilon (CKIε), a novel member of the CKI gene family. J Biol Chem 1995;270:14875-14883.
104. Vielhaber E, Eide E, Rivers A, Gao ZH, Virshup DM: Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I epsilon. Mol Cell Biol 2000;20:4888-4899.
105. Lowrey PL, Shimomura K, Antoch MP, Yamazaki S, Zemenides PD, Ralph MR, Menaker M, Takahashi JS: Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science 2000;288:483-492.
106. Polakis P: Casein kinase 1: A Wnt'er of disconnect. Curr Biol 2002;12:R499-R501.
107. Peters JM, McKay RM, McKay JP, Graff JM: Casein kinase I transduces Wnt signals. Nature 1999;401:345-350.
108. Sakanaka C, Leong P, Xu L, Harrison SD, Williams LT: Casein kinase Iepsilon in the Wnt pathway: Regulation of β-catenin function. Proc Natl Acad Sci USA 1999;96:12548-12552.
109. Gao ZH, Seeling JM, Hill V, Yochum A, Virshup DM: Casein kinase I phosphorylates and destabilizes the β-catenin degradation complex. Proc Natl Acad Sci USA 2002;99:1182-1187.
110. Hino S, Michiue T, Asashima M, Kikuchi A: Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin. J Biol Chem 2003;278:14066-14073.
111. Polakis P: Wnt signaling and cancer. Genes Dev 2000;14:1837-1851.
112. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I: Axin-mediated CKI phosphorylation of β-catenin at Ser 45: A molecular switch for the Wnt pathway. Genes Dev 2002;16:1066-1076.
113. Sussman DJ, Klingensmith J, Salinas P, Adams PS, Nusse R, Perrimon N: Isolation and characterization of a mouse homolog of the Drosophila segment polarity gene dishevelled. Dev Biol 1994;166:73-86.
114. Willert K, Brink M, Wodarz A, Varmus H, Nusse R: Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J 1997;16:3089-3096.
115. Jonkers J, Korswagen HC, Acton D, Breuer M, Berns A: Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas. EMBO J 1997;16:441-450.
116. Kadoya T, Yamamoto H, Suzuki T, Yukita A, Fukui A, Michiue T, Asahara T, Tanaka K, Asashima M, Kikuchi A: Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of β-catenin. Mol Cell Biol 2002;22:3803-3819.
117. Yamamoto H, Ihara M, Matsuura Y, Kikuchi A: Sumoylation is involved in β-catenin-dependent activation of Tcf-4. EMBO J 2003;22:2047-2059.
118. Herz J, Strickland DK: LRP: A multifunctional scavenger and signaling receptor. J Clin Invest 2001;108:779-784.
119. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC: An LDL-receptor-related protein mediates Wnt signaling in mice. Nature 2000;407:535-538.
120. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X: LDL-receptor-related proteins in Wnt signal transduction. Nature 2000;407:530-535.
121. Semenov MV, Tamai K, Brott BK, Kuhl M, Sokol S, He X: Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 2001;11:951-961.
122. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-1912.
123. Hagemann C, Blank JL: The ups and downs of MEK kinase interactions. Cell Signal 2001;13:863-875.
124. Schmidt D, Müller S: Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 2002;99:2872-2877.
125. Müller S, Hoege C, Pyrowolakis G, Jentsch S: SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol 2001;2:202-210.
126. Kwek SS, Derry J, Tyner AL, Shen Z, Gudkov AV: Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 2001;20:2587-2599.
127. Melchior F, Hengst L: SUMO-1 and p53. Cell Cycle 2002;1:245-249.
128. Verger A, Perdomo J, Crossley M: Modification with SUMO: A role in transcriptional regulation. EMBO Rep 2003;4:137-142.
129. Pepper MS: Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997;8:21-43.
130. Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T, Klein R: Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 1996;86:35-46.
131. Birgbauer E, Cowan CA, Sretavan DW, Henkemeyer M: Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina. Development 2000;127:1231-1241.
132. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR: CAP defines a second signaling pathway required for insulin-stimulated glucose transport. Nature 2000;407:202-207.
133. Yamazaki H, Yanagawa S: Axin and Axin/Arrow-binding protein DCAP mediate glucose-glycogen metabolism. Biochem Biophys Res Commun 2003;304:229-235.